Pro Medicus (PME.AX) Earnings Analysis

Pro Medicus (PME.AX) next reports earnings on 2026-08-18, consensus EPS 0.884 AUD. Last quarter (2025-02-13) it beat with EPS 0.4818 AUD vs 0.4789 AUD est (+0.6%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E 72.06.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PME.AX next report earnings?

Next earnings date2026-08-18
Consensus EPS estimate0.884 AUD
Revenue estimate0.14B

PME.AX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-02-130.4818 AUD0.4789 AUD+0.6%Beat
2024-08-140.4499 AUD0.4142 AUD+8.6%Beat

Beat rate: 2/2 (100%) over reported quarters with consensus data.

PME.AX valuation and analyst view

Trailing P/E72.06
Trailing EPS2.246 AUD
Price / book43.55
Dividend yield0.38%
Market cap18.12B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Pro Medicus (PME.AX)'s next earnings date?

Pro Medicus is next scheduled to report on 2026-08-18, with a consensus EPS estimate of 0.884 AUD and revenue estimate of 0.14B.

Did PME.AX beat earnings last quarter?

In its 2025-02-13 report, PME.AX posted EPS of 0.4818 AUD versus a 0.4789 AUD estimate — a beat of 0.6%.

What is PME.AX's earnings track record?

Over the last 2 reported quarters with consensus data, PME.AX beat estimates 2 times (100%).

What is PME.AX's current P/E ratio and EPS?

PME.AX trades at a trailing P/E of 72.06 on trailing EPS of 2.2462996688661696 AUD.

What do analysts rate PME.AX?

PME.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.